EAGLE PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On January 7, 2020, Eagle Pharmaceuticals, Inc., or the Company, issued a press release announcing the Company's entrance into a strategic collaboration with Tyme Technologies, Inc. to advance oral SM-88 for the treatment of patients with cancer.

A copy of the full text of the press release referenced above is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

 (d) Exhibits




Exhibit No.                            Description
    99.1          Press Release dated January 7, 2020

     104        Cover Page Interactive Data file (formatted as inline XBRL)

© Edgar Online, source Glimpses